This post was just published on ZYX Buy Change Alert.

OraSure (OSUR) is developing a rapid in-home coronavirus test.  Previously it received a  $710,310 contract from the Biomedical Advanced Research and Development Authority which is part of the Department of Health and Human Services to develop a rapid in-home coronavirus test.  This was a very small contract. However looking forward, if this test is quickly approved by the FDA, imagine the volume they could generate just from consumers buying it.

OraSure stock was purchased at an average price of $10.56. The first target zone was $13.73 to $16.14. Targets and stop zones are typically given in advance at the same time as the buy signal is given.  Orasur is trading at $15.30 as of this writing.  All subscribers should have taken partial profits.

The second target was $17.73 to $22.  However the way this stock market is behaving, if there is good news from this company, OSUR stock can easily run over $30 in a short squeeze.

What To Do Now

Those in the stock may consider continuing to hold.

Those not in the stock and are super aggressive and understand the risk  of buying now may consider buying a very small tranche such as 5 – 10% of full core position size in the zone of $14.44 to $15.36.

Based on the news a signal may be given to add more or take profits.


Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007.  Please click here and scroll down to see the table of all trades.  These trades have been scrutinized in real-time by thousands of investors across the globe.  This provides easy verification of performance for newcomers to this site.  Only those trades are included in the performance where the entry post was made available to subscribers to The Arora Report Market Blog.  When the entry post is made available only to the paying subscribers and not posted in real-time on The Arora Report Market Blog, the resulting performance of the trade is not credited in the performance table.  There are very nice gains on this trade but since the entry trade was not posted here for the free subscribers in real-time but only made available to the paying subscribers, handsome profits on this trade will not be added to the performance of The Arora Report Market Blog shown on the table.

A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence